1) HLA-DRw53
人类白细胞抗原DRw53
1.
Objective To observed the variations of quantity of human leucocyte antigen DRw53 gene (HLA-DRw53) expressed in allergic vasculaitis patients before and after treatment.
目的探讨人类白细胞抗原DRw53(HLA-DRw53)基因在变应性血管炎患者治疗前后mRNA表达量的变化。
2) HLA
人类白细胞抗原
1.
Application of human leukocyte antigen(HLA)-amino acid residue matching in kidney transplantion;
人类白细胞抗原——氨基酸残基配型在肾移植中的应用
2.
Study on association of HLA-DRB1 alleles with gastric carcinoma and Helicobacter pylori infection;
人类白细胞抗原-DRB1与胃腺癌及其临床特征和幽门螺杆菌感染的相关性
3.
Application of HLA genotyping method in hematopoietic stem cell transplantation;
人类白细胞抗原(HLA)基因分型在造血干细胞移植中的应用
3) human leukocyte antigen
人类白细胞抗原
1.
Association of genetic polymorphisms in human leukocyte antigen-DQA1 with intrahepatic cholestasis of pregnancy in Chengdu district;
成都地区妊娠期肝内胆汁淤积症与人类白细胞抗原-DQA1的相关性研究
2.
Relationship between the polymorphism of human leukocyte antigen and genetic susceptibility for chronic renal failure
人类白细胞抗原多态性与慢性肾功能衰竭的遗传易感性研究
3.
Objective To explore the effectiveness and complications of hematopoietic stem cell transplantation(HSCT) from human leukocyte antigen(HLA)-mismatched related donors in the treatment of haematological diseases.
目的评价亲缘人类白细胞抗原(HLA)配型不合造血干细胞移植(HSCT)治疗血液病的疗效和并发症。
5) human leukocye antigen A
人类白细胞抗原-A
6) human leucocyte antigen
人类白细胞抗原
1.
Progress in study on relationship between nonclassical human leucocyte antigenI and immunology in pregnancy;
非经典人类白细胞抗原I类分子与妊娠免疫
2.
Recombination within the human leucocyte antigen;
人类白细胞抗原分子遗传中的基因重组
3.
Objective To understand the characteristic and merit of new polymerase chain reaction restriction sequence specific oligonacleotide(PCR-SSO)technique by analyzing the human leucocyte antigen-B(HLA-B) genetype in Eales disease and control group.
目的通过使用新型聚合酶链反应-序列特异的寡核苷酸扩增分析(polymerasechainreactionrestrictionsequencespecificoligonucleotide,PCR-SSO)方法分析Eales病患者及正常人群的人类白细胞抗原B组(humanleucocyteantigen-B,HLA-B)基因型,了解这种方法的特点及其优越性。
补充资料：人类白细胞抗原
人类白细胞抗原
human leucocyte antigen,HLA
是一种主要的组织相容性抗原系统，具有多种特性，HLA与ABO抗原均能引起移植组织的排斥反应。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条